Cover Image
市場調查報告書

免疫診斷的中國市場 (2016∼2020年)

Immunodiagnostics Market in China 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 338879
出版日期 內容資訊 英文 103 Pages
訂單完成後即時交付
價格
Back to Top
免疫診斷的中國市場 (2016∼2020年) Immunodiagnostics Market in China 2016-2020
出版日期: 2015年11月18日 內容資訊: 英文 103 Pages
簡介

中國的免疫診斷市場至2020年的年複合成長率(CAGR) 預計達到約18%。嚴格醫療改革的實施,及國內診斷設備製造商普及擴大,市場競爭加劇,再加上都市化的發展伴隨的慢性疾病 (癌症、糖尿病、心血管疾病、肺炎等) 的患者增加等,成為市場成長的主要原因。各診斷技術中,化學冷光法 (CLIA) 佔最大的市場佔有率。還有在各產品種類中,各種試劑成為市場整體約82%。

本報告提供中國國內的免疫診斷市場相關分析、市場&醫療制度概要和結構、市場規模趨勢 (今後5年的預測值)、各產品種類與各診斷技術詳細趨勢、推動&阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 中國的醫療制度

  • 中國的健康保險制度
  • 中國的法規環境
  • 中國國內的流通網路

第6章 市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第7章 各產品種類的市場區隔

  • 免疫診斷試劑
  • 免疫診斷用設備
  • 中國國內的免疫診斷試劑市場
  • 中國國內的免疫診斷用設備市場

第8章 分析器的各種類的市場區隔

第9章 各操作模式的市場區隔

第10章 各診斷技術的市場區隔

  • CLIA (化學冷光免疫檢測) 市場
  • ELISA (酵素結合免疫吸附檢測) 市場
  • FIA (螢光免疫分析法) 市場
  • MIA (多重免疫檢測) 市場
  • LFIA (側流免疫檢測) 市場
  • RIA (輻射標識免疫檢測) 市場

第11章 推動市場要素

第12章 推動因素與其影響力

第13章 市場課題

第14章 推動因素、課題的影響力

第15章 市場趨勢

第16章 供應商環境

  • 市場佔有率分析
  • 第1級供應商分析

第17章 主要供應商分析

  • Abbott Diagnostics
  • Beckman Coulter Trading (China)
  • bioMrieux China
  • DiaSorin
  • Mindray
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics (Shanghai)
  • Sysmex Medical Electronics (Shanghai)

第18章 附錄

  • 簡稱集

第19章 關於Technavio

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR7854

Covering: This market research report includes a detailed segmentation of the immunodiagnostic market in China by technology type (CLIA, ELISA, FIA, MIA, LFIA, and RIA), by product (reagent and instrument), by analyzer type (standalone analyzer and integrated analyzer), and by mode of operation (automated systems, semi-automated systems, and manual systems). The key vendors in this report are Roche Diagnostics, Abbott Diagnostics, Siemens Healthcare Diagnostics, Beckman Coulter, and Sysmex Medical Electronics.

Market outlook of the immunodiagnostic market in the China

Technavios market research analyst estimates the immunodiagnostics market in China to grow at an impressive CAGR of around 18% by 2020. The introduction of stringent healthcare reforms, growing preference for local manufacture of diagnostic devices, and rapidly increasing competition are some of the significant factors that augment growth in this market during the forecast period.

The rising prevalence of infectious and chronic diseases in this region is the primary growth driver for this market. In China, urbanization has led to an increase in the prevalence of chronic diseases like cancer, diabetes, cardiovascular diseases, and tuberculosis. This high prevalence of chronic diseases is envisaged to bolster the need for immunodiagnostic tests, which in turn would result in market growth during the forecast period.

Competitive landscape and key vendors

The immunodiagnostic market in the China is consolidated due to the presence of numerous small, medium, and large vendors. The vendors in this market compete on the basis of product differentiation, application differentiation, portfolio, and pricing to gain maximum market traction during the forecast period.

The top vendors in the market are -

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthcare Diagnostics
  • Beckman Coulter
  • Sysmex Medical Electronics (Shangai)

Other prominent vendors in the market include AccuBio Tech,Alere,Becton Dickinson,Beijing Kewei Clinical Diagnostics Reagents, Beijing Leadman Biochemistry,Bio-RadBioscience Diagnostic Technology,Biosino Biotechnology & Science, DIAsource, DiaSys Diagnostic Systems, Fosun Pharma, Getein Biotechnology, Hitachi, Immunodiagnostic System Holdings, Luminex, NewScen Coast Bio-Pharmaceutical, Ortho Clinical Diagnostics, Shanghai Kehua Bio-engineering, Sichuan Maccura Biotechnology, Tecan, and Thermofisher Scientific.

Technological segmentation of the immunodiagnostic market in China

  • ELISA
  • CLIA
  • RIA
  • FIA
  • MIA
  • LFIA

According to this global market research report, the chemiluminescence (CLIA) assay segment is anticipated to be the largest market segment during the forecast period. The ability of this assay to perform clinical applications at a rapid pace is a major factor that augments its adoption during the forecast period. Moreover, this assays ability to make sample detection sensitive and easy is envisaged to result in its profound market share of more than 66% by 2020.

Product-type segmentation and analysis of the immunodiagnostic market in China

  • Reagent
  • Instrument

Technavio market research analysts estimate the reagents segment to account for a market share of approximately 82% during the forecast period. The ability of reagents to diagnose minute quantities of biological agents like hormones, viruses, vitamins, or immunogenic substances in blood samples is anticipated to result in its high adoption during the predicted period.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020
  • What are the key factors driving the immunodiagnostic market in the China
  • What are the key market trends impacting the growth of the immunodiagnostic market in the China
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the vendors in the immunodiagnostic market in the China
  • What are the key outcomes of the five forces analysis of the immunodiagnostic market in the China

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Healthcare system in China

  • Health insurance system in China
  • Regulatory landscape of China
  • Distribution network in China

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by product type

  • Immunodiagnostic reagents
  • Immunodiagnostic instruments
  • Immunodiagnostic reagents market in China
  • Immunodiagnostic instruments market in China

PART 08: Market segmentation by analyzer type

PART 09: Market segmentation by mode of operation

PART 10: Market segmentation by technology

  • CLIA market in China
  • ELISA market in China
  • FIA market in China
  • MIA market in China
  • LFIA market in China
  • RIA market in China

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

  • Market share analysis
  • Analysis of tier 1 vendors

PART 17: Key vendor analysis

  • Abbott Diagnostics
  • Beckman Coulter Trading (China)
  • bioMrieux China
  • DiaSorin
  • Mindray
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics (Shanghai)
  • Sysmex Medical Electronics (Shanghai)

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Hospital distribution in China 2015
  • Exhibit 03: Hospital segmentation in China
  • Exhibit 04: Distribution of healthcare institutions in China
  • Exhibit 05: Health insurance system in China
  • Exhibit 06: Regulatory process for approval of medical devices in China
  • Exhibit 07: Distribution network in China 2013
  • Exhibit 08: Immunodiagnostics market in China
  • Exhibit 09: Immunodiagnostics market in China 2015-2020 ($ millions)
  • Exhibit 10: Five forces analysis
  • Exhibit 11: Immunodiagnostics market in China by product type
  • Exhibit 12: Segmentation of immunodiagnostics market in China by product type 2015
  • Exhibit 13: Segmentation of immunodiagnostics market in China by product type 2020
  • Exhibit 14: Immunodiagnostic reagents market in China market 2015-2020 ($ millions)
  • Exhibit 15: Immunodiagnostic instruments market in China 2015-2020 ($ millions)
  • Exhibit 16: Segmentation of immunodiagnostics market in China by analyzer type
  • Exhibit 17: Segmentation of immunodiagnostics market in China by analyzer type 2015
  • Exhibit 18: Segmentation by mode of operation
  • Exhibit 19: Segmentation of immunodiagnostics market in China by mode of operation 2015
  • Exhibit 20: Segmentation of the immunodiagnostics market in China by technology
  • Exhibit 21: Segmentation of immunodiagnostics market by technology 2015
  • Exhibit 22: Segmentation of immunodiagnostics market by technology 2020
  • Exhibit 23: CLIA market in China 2015-2020 ($ millions)
  • Exhibit 24: ELISA market in China 2015-2020 ($ millions)
  • Exhibit 25: FIA market in China 2015-2020 ($ millions)
  • Exhibit 26: MIA market in China 2015-2020 ($ millions)
  • Exhibit 27: LFIA market in China 2015-2020 ($ millions)
  • Exhibit 28: RIA market in China 2015-2020 ($ millions)
  • Exhibit 29: Segmentation of immunodiagnostics market in China by technology 2015-2020
  • Exhibit 30: Impact of drivers
  • Exhibit 31: Impact of drivers and challenges
  • Exhibit 32: Competitive positioning of vendors
  • Exhibit 33: Abbott Diagnostics: Key takeaways
  • Exhibit 34: Beckman Coulter Diagnostics: Key takeaways
  • Exhibit 35: Roche Diagnostics: Key takeaways
  • Exhibit 36: Siemens Healthcare Diagnostics: Key takeaways
  • Exhibit 37: Abbott Diagnostics: Business segmentation
  • Exhibit 38: Beckman Coulter Trading (China): Business segmentation
  • Exhibit 39: bioMrieux China: Business segmentation
  • Exhibit 40: DiaSorin: Technology segmentation by revenue 2014
  • Exhibit 41: DiaSorin: Technology segmentation by revenue 2013 and 2014
  • Exhibit 42: DiaSorin: Geographical segmentation by revenue 2014
  • Exhibit 43: Mindray: Business segmentation by revenue 2014
  • Exhibit 44: Mindray: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 45: Mindray: Geographical segmentation by revenue 2014
  • Exhibit 46: Mindray: Geographical segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 47: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 48: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 49: Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 50: Roche Diagnostics: Geographical segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 51: Roche Diagnostics: Sales in emerging markets
  • Exhibit 52: Siemens Healthcare Diagnostics (Shanghai): Business segmentation
  • Exhibit 53: Sysmex Medical Electronics (Shanghai): Business segmentation by revenue 2014 (% share)
  • Exhibit 54: Sysmex Medical Electronics (Shanghai): Business segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 55: Sysmex Medical Electronics (Shanghai): Product segmentation by revenue 2015
  • Exhibit 56: Sysmex Medical Electronics (Shanghai): Product segmentation by revenue 2014 and 2015 ($ millions)
Back to Top